Upregulation of ventricular potassium channels by chronic tamoxifen treatment

Cardiovascular Research

Volumn 90, Issue 1, 2011, Pages 68-76

  El Gebeily, Gracia ^a,b   Fiset, Céline ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Guinea pig; K+ currents; Mouse; Oestrogen; Tamoxifen

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; PLACEBO; POTASSIUM CHANNEL HERG; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNQ1; POTASSIUM CHANNEL KV1.5; POTASSIUM CHANNEL KV2.1; POTASSIUM CHANNEL KV4.3; POTASSIUM ION; TAMOXIFEN; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL GUINEA PIG; FEMALE; HEART VENTRICLE; INWARD RECTIFIER POTASSIUM CURRENT; LONG TERM CARE; MOUSE; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPONTANEOUS TRANSIENT OUTWARD CURRENT; STEADY STATE; STEADY STATE POTASSIUM CURRENT; ULTRARAPID DELAYED RECTIFIER POTASSIUM CURRENT; UPREGULATION;

ACTION POTENTIALS; ANIMALS; BLOTTING, WESTERN; DRUG IMPLANTS; FEMALE; GUINEA PIGS; HEART VENTRICLES; ION CHANNEL GATING; KINETICS; MICE; PATCH-CLAMP TECHNIQUES; POTASSIUM; POTASSIUM CHANNELS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; UP-REGULATION;

EID: 79952853030     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq384     Document Type: Article

References (44)

1. Osipo C, Liu H, Meeke K, Jordan VC. The consequences of exhaustive antiestrogen therapy in breast cancer: estrogen-induced tumor cell death. Exp Biol Med (Maywood) 2004;229:722-731. (Pubitemid 39166476)
2. Jordan VC. Tamoxifen: a most unlikely pioneering medicine. Nat Rev Drug Discov 2003; 2:205-213. (Pubitemid 37361665)
3. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-1388. (Pubitemid 28439961)
4. Jordan VC, Morrow M. Tamoxifen, raloxifene, and the prevention of breast cancer. Endocr Rev 1999;20:253-278. (Pubitemid 30649808)
5. Jordan VC. Overview from the International Conference on Long-Term Tamoxifen Therapy for Breast Cancer. J Natl Cancer Inst 1992;84:231-234.
6. Park WC, Jordan VC. Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention. Trends Mol Med 2002;8:82-88. (Pubitemid 34094444)
7. Winer EP, Hudis C, Burstein HJ, Chlebowski RT, Ingle JN, Edge SB et al. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. J Clin Oncol 2002;20:3317-3327. (Pubitemid 34831529)
8. McDonald CC, Alexander FE, Whyte BW, Forrest AP, Stewart HJ. Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. The Scottish Cancer Trials Breast Group. BMJ 1995;311:977-980.
9. Rutqvist LE, Mattsson A. Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group. J Natl Cancer Inst 1993;85: 1398-1406. (Pubitemid 23264348)
10. Pollack IF, DaRosso RC, Robertson PL, Jakacki RL, Mirro JR Jr, Blatt J et al. A phase I study of high-dose tamoxifen for the treatment of refractory malignant gliomas of childhood. Clin Cancer Res 1997;3:1109-1115. (Pubitemid 27319757)
11. Trump DL, Smith DC, Ellis PG, Rogers MP, Schold SC, Winer EP et al. High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine. J Natl Cancer Inst 1992;84:1811-1816.
12. Best L. Inhibition of glucose-induced electrical activity by 4-hydroxytamoxifen in rat pancreatic beta-cells. Cell Signal 2002;14:69-73. (Pubitemid 34020831)
13. Diaz M. Triphenylethylene antiestrogen-induced acute relaxation of mouse duodenal muscle. Possible involvement of Ca2+ channels. Eur J Pharmacol 2002;445:257-266. (Pubitemid 34655683)
14. He J, Kargacin ME, Kargacin GJ, Ward CA. Tamoxifen inhibits Na+ and K+ currents in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 2003;285:H661-H668. (Pubitemid 36885898)
15. Liu XK, Katchman A, Ebert SN, Woosley RL. The antiestrogen tamoxifen blocks the delayed rectifier potassium current, IKr, in rabbit ventricular myocytes. J Pharmacol Exp Ther 1998;287:877-883. (Pubitemid 29131595)
16. Thomas D, Gut B, Karsai S, Wimmer AB, Wu K,Wendt-Nordahl G et al. Inhibition of cloned HERG potassium channels by the antiestrogen tamoxifen. Naunyn Schmiedebergs Arch Pharmacol 2003;368:41-48. (Pubitemid 36960483)
17. Song J, Standley PR, Zhang F, Joshi D, Gappy S, Sowers JR et al. Tamoxifen (estrogen antagonist) inhibits voltage-gated calcium current and contractility in vascular smooth muscle from rats. J Pharmacol Exp Ther 1996;277:1444-1453.
18. Dick GM, Rossow CF, Smirnov S, Horowitz B, Sanders KM. Tamoxifen activates smooth muscle BK channels through the regulatory beta 1 subunit. J Biol Chem 2001;276: 34594-34599.
19. El Gebeily G, Fiset C. 4-Hydroxytamoxifen inhibits K+ currents in mouse ventricular myocytes. Eur J Pharmacol 2010;629:96-103.
20. Chen J, Power KA, Mann J, Cheng A, Thompson LU. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Exp Biol Med 2007;232:1071-1080. (Pubitemid 47358190)
21. Tsang SY, Yao X, Wong CM, Chan FL, Chen ZY, Huang Y. Differential regulation of K+ and Ca2+ channel gene expression by chronic treatment with estrogen and tamoxifen in rat aorta. Eur J Pharmacol 2004;483:155-162. (Pubitemid 38068396)
22. Liu B, Edgerton S, Yang X, Kim A, Ordonez-Ercan D, Mason T et al. Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention. Cancer Res 2005;65:879-886. (Pubitemid 40216447)
23. Trépanier-Boulay V, St-Michel C, Tremblay A, Fiset C. Gender-based differences in cardiac repolarization in mouse ventricle. Circ Res 2001;89:437-444. (Pubitemid 34132660)
24. Brouillette J, Clark RB, Giles WR, Fiset C. Functional properties of K+ currents in adult mouse ventricular myocytes. J Physiol 2004;559:777-798. (Pubitemid 39276168)
25. Lizotte E, Tremblay A, Allen BG, Fiset C. Isolation and characterization of subcellular protein fractions from mouse heart. Anal Biochem 2005;345:47-54. (Pubitemid 41558193)
26. Brouillette J, Lupien MA, St Michel C, Fiset C. Characterization of ventricular repolarization in male and female guinea pigs. J Mol Cell Cardiol 2007;42:357-366. (Pubitemid 46135610)
27. Rasmusson RL, Morales MJ, Wang S, Liu S, Campbell DL, Brahmajothi MV et al. Inactivation of voltage-gated cardiac K+ channels. Circ Res 1998;82:739-750.
28. Salama G, London B. Mouse models of long QT syndrome. J Physiol 2007;578:43-53. (Pubitemid 44971109)
29. Sanguinetti MC. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 1995;81:299-307.
30. Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL et al. Coassembly of KvLQT1 and minK (IsK) proteins to form cardiac IKs potassium channel. Nature 1996;384:80-83. (Pubitemid 26374592)
31. Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G. KvLQT1 and IsK (minK) proteins associate to form the IKs cardiac potassium current. Nature 1996; 384:78-80. (Pubitemid 26374591)
32. Sanguinetti MC, Jurkiewicz NK. Two components of cardiac delayed rectifier K+ current: differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 1990;96:195-215. (Pubitemid 20227082)
33. Liu H, Jin MW, Xiang JZ, Huang Y, Sun HY, Chiu SW et al. Raloxifene inhibits transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes. Eur J Pharmacol 2007;563:61-68. (Pubitemid 46602229)
34. Eghbali M, Deva R, Alioua A, Minosyan TY, Ruan H, Wang Y et al. Molecular and functional signature of heart hypertrophy during pregnancy. Circ Res 2005;96: 1208-1216. (Pubitemid 40827697)
35. Song M, Helguera G, Eghbali M, Zhu N, Zarei MM, Olcese R et al. Remodeling of Kv4.3 Potassium Channel Gene Expression under the Control of Sex Hormones. J Biol Chem 2001;276:31883-31890.
36. Saito T, Ciobotaru A, Bopassa JC, Toro L, Stefani E, Eghbali M. Estrogen contributes to gender differences in mouse ventricular repolarization. Circ Res 2009;105:343-352.
37. Fiset C, Clark RB, Shimoni Y, Giles WR. Shal-type channels contribute to the Ca2+-independent transient outward K+ current in rat ventricle. J Physiol 1997;500.1: 51-64. (Pubitemid 27165831)
38. Shimoni Y, Fiset C, Clark RB, Dixon JE, McKinnon D, Giles WR. Thyroid hormone regulates postnatal expression of transient K+ channel isoforms in rat ventricle. J Physiol 1997;500.1:65-73. (Pubitemid 27165832)
39. Guo W, Xu H, London B, Nerbonne JM. Molecular basis of transient outward K+ current diversity in mouse ventricular myocytes. J Physiol 1999;521:587-599. (Pubitemid 30042774)
40. Wickenden AD, Lee P, Sah R, Huang Q, Fishman GI, Backx PH. Targeted expression of a dominant-negative Kv4.2 K+ channel subunit in the mouse heart. Circ Res 1999; 85:1067-1076.
41. Barry DM, Xu H, Schuessler RB, Nerbonne JM. Functional knockout of the transient outward current, long-QT syndrome, and cardiac remodelling in mice expressing a dominant-negative Kv4 a-subunit. Circ Res 1998;83:560-567. (Pubitemid 28411058)
42. Rivard K, Trépanier-Boulay V, Rindt H, Fiset C. Electrical remodeling in a transgenic mouse model of a1B-adrenergic receptor overexpression. Am J Physiol Heart and Circ 2009;296:H704-H718.
43. Rivard K, Paradis P, Nemer M, Fiset C. Cardiac-specific overexpression of the human type 1 angiotensin II receptor causes delayed repolarization. Cardiovasc Res 2008;78: 53-62. (Pubitemid 351430969)
44. El Gebeily G, Brouillette J, Fiset C. Regulation of ventricular repolarization by estrogen and estrogen receptors in mouse. International Society for Heart Research Cell to Bedside-Meeting Processing, 30th North American Section Meeting 53. 2008.